JPH0361437B2 - - Google Patents
Info
- Publication number
- JPH0361437B2 JPH0361437B2 JP4701883A JP4701883A JPH0361437B2 JP H0361437 B2 JPH0361437 B2 JP H0361437B2 JP 4701883 A JP4701883 A JP 4701883A JP 4701883 A JP4701883 A JP 4701883A JP H0361437 B2 JPH0361437 B2 JP H0361437B2
- Authority
- JP
- Japan
- Prior art keywords
- threo
- strain
- acid
- water
- hydroxyaspartic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- YYLQUHNPNCGKJQ-LWMBPPNESA-N (3S)-3-hydroxy-L-aspartic acid Chemical compound OC(=O)[C@@H](N)[C@H](O)C(O)=O YYLQUHNPNCGKJQ-LWMBPPNESA-N 0.000 claims description 18
- YYLQUHNPNCGKJQ-UHFFFAOYSA-N erythro-beta-hydroxy-L-aspartic acid Natural products OC(=O)C(N)C(O)C(O)=O YYLQUHNPNCGKJQ-UHFFFAOYSA-N 0.000 claims description 16
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 241001495437 Dactylosporangium Species 0.000 claims description 6
- 241000866033 Dactylosporangium sp. Species 0.000 claims description 2
- 235000015097 nutrients Nutrition 0.000 claims description 2
- 238000000034 method Methods 0.000 description 17
- 239000000126 substance Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 239000002609 medium Substances 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 5
- YDBVAWZTOAZPTJ-REOHCLBHSA-N (2s)-2-(hydroxyamino)butanedioic acid Chemical compound ON[C@H](C(O)=O)CC(O)=O YDBVAWZTOAZPTJ-REOHCLBHSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 description 3
- 229940041514 candida albicans extract Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- 241000186361 Actinobacteria <class> Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- VSTAZHARNIVHNV-JIZZDEOASA-L [Na+].[Na+].ON[C@@H](CC(=O)[O-])C(=O)[O-] Chemical compound [Na+].[Na+].ON[C@@H](CC(=O)[O-])C(=O)[O-] VSTAZHARNIVHNV-JIZZDEOASA-L 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000013587 production medium Substances 0.000 description 2
- AFHFWLNCUQBZAU-UHFFFAOYSA-N propan-1-ol 2-pyridin-2-ylacetic acid hydrate Chemical compound O.CCCO.OC(=O)CC1=CC=CC=N1 AFHFWLNCUQBZAU-UHFFFAOYSA-N 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 241001446247 uncultured actinomycete Species 0.000 description 2
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WFIYPADYPQQLNN-UHFFFAOYSA-N 2-[2-(4-bromopyrazol-1-yl)ethyl]isoindole-1,3-dione Chemical compound C1=C(Br)C=NN1CCN1C(=O)C2=CC=CC=C2C1=O WFIYPADYPQQLNN-UHFFFAOYSA-N 0.000 description 1
- VUEOQWDVOXEFDJ-UHFFFAOYSA-N 2-pyridin-2-ylacetic acid;hydrate Chemical compound O.OC(=O)CC1=CC=CC=N1 VUEOQWDVOXEFDJ-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000171735 Arthrinium phaeospermum Species 0.000 description 1
- 108010005694 Aspartate 4-decarboxylase Proteins 0.000 description 1
- 241000123650 Botrytis cinerea Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187481 Mycobacterium phlei Species 0.000 description 1
- HOKKHZGPKSLGJE-GSVOUGTGSA-N N-Methyl-D-aspartic acid Chemical compound CN[C@@H](C(O)=O)CC(O)=O HOKKHZGPKSLGJE-GSVOUGTGSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- FWMBCNGLMRSLPH-UHFFFAOYSA-N O.OC=O.CC(O)=O Chemical compound O.OC=O.CC(O)=O FWMBCNGLMRSLPH-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- -1 Remieux Chemical compound 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000589652 Xanthomonas oryzae Species 0.000 description 1
- MHLMRBVCMNDOCW-UHFFFAOYSA-N acetic acid;butan-1-ol;hydrate Chemical compound O.CC(O)=O.CCCCO MHLMRBVCMNDOCW-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 231100000219 mutagenic Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 229940055036 mycobacterium phlei Drugs 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 238000004816 paper chromatography Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明はL−スレオ−β−ヒドロキシアスパラ
ギン酸の製造法に関する。L−スレオ−β−ヒド
ロキシアスパラギン酸はそれ自体抗菌活性を有す
る。即ちバチルス・ズブチリス(Bacillus
subtilis)、キサントモナス・オリゼ
(Xanthomonas oryzae)、ミコバクテリウム・
フレイ(Mycobacterium phlei)及びボトリテ
イス・シネリ(Botrytis cinerea)等の細菌に有
効であることが知られている(参考文献1.
Ishiyama 等、Journal of Antibiotics、23巻、
821頁、1975年)。
一方、本物質は生体で重要な役割を演ずるアミ
ノ酸の一種であるL−アスパラギン酸の類縁体と
見做すことが出来、生体酵素系に関与して重要な
生理活性を有することが知られている。例えばL
−アスパルテートβ−デカ−ボキシラーゼ(L−
Aspartate β−decarboxylase)の阻害剤である
ことが知られている(参考文献2.E.W.Miles and
A.Meister、Biochemistry 6巻、1734頁、1967
年)。また、脳の興奮刺激剤アミノ酸であるN−
メチル−D−アスパラギン酸の大脳皮質での吸収
をL−スレオ−β−ヒドロキシアスパラギン酸が
抑制することを報告されている(参考文献3.J.H.
Skerritt andG.A.R.Johnston、Journal of
Neurochemistry、36巻、881頁、1981年)。
以上の如く、L−スレオ−β−ヒドロキシアス
パラギン酸は抗菌剤並びに生理活性物質としてそ
れ自体有用であるのみならず、一種のアミノ酸と
して安価に供給出来れば医薬やその他工業的に有
用な化合物の合成原料または素材として用いられ
る可能性が高い。
本物質の製造に当つては動植物体から抽出精製
する方法は可能であるが、原料の制限及び含有量
の少ないことから工業的に不利である。合成によ
る方法は可能であり色々な方法が知られている
が、β−ヒドロキシアスパラギン酸には4種の立
体異性体、即ちスレオ型とエリスロ型及びそれら
のD及びL体の計4種の異性体を生じ、L−スレ
オ体のみを単離する必要があり、必ずしも工業的
に有利な方法とは云えない。これらの方法に対し
微生物を用いる醗酵法は、立体異性体の特定のも
ののみに限定された化合物のみを効率的に生産出
来るので工業的に極めて有利な製造法であると云
える。
L−スレオ−β−ヒドロキシアスパラギン酸を
醗酵生産する微生物としてカビの一種であるアー
スリニウム・フエオスパーマム(Arthrinum
phaeospermum)及び放線菌であるストレプトミ
セス属(Streptomyces)の1菌株が知られてい
るに過ぎない(参考文献1)。本発明者らは放線
菌であるダクチロスポランギウム属
(Dactylosporangium)の1菌株がL−スレオ−
β−ヒドロキシアスパラギン酸の醗酵生産能を有
し、しかもその培養液中に効率よく高濃度に生産
蓄積することを発見し、本発明を完了するに至つ
た。以下にその方法を説明する。
本発明に用いる微生物菌株の1例として、本発
明者らが京都市内の土壌より分離したダクチロス
ポランギウム属に属するSF−2253株がある。SF
−2253株の菌学的性状は下記に記述する通りであ
る。観察は主としてE.B.ShirlingとD.Gottliebの
方法(International Journal of Systematic
Bacteriology、16巻、313〜340頁、1966年)に
従つて実施した。
形態
基生菌糸はよく分枝して波状に伸長し、直径は
0.5〜0.6ミクロンである。寒天培地及び液体培地
のいずれにおいても基生菌糸の分断は観察されな
い。気菌糸はほとんど見られず、事実上形成しな
いと思われる。SF−2253株は寒天培地の表面に
胞子のうを1個あるいはタフト状に形成する。胞
子のうは、スターチ寒天培地上で比較的多く認め
られる。胞子のうは指状で、大きさはおよそ0.7
〜1.0×2.0〜4.0ミクロンである。各胞子のうは中
に1列に通常3〜4個の胞子を持つ。胞子は大部
分が円筒形ないし卵形で表面はなめらか、大きさ
はおよそ0.6〜0.9×0.9〜1.8ミクロンである。胞
子はたとえば土壌抽出液などに懸濁し、15〜30分
放置した後検鏡すると運動性が認められた。
各種培地上の生育状態
SF−2253株の各種培地上の生育状態は次表に
示す通りである。色の記載において〔 〕内に示
す標準はコンテナー・コーポレーシヨン・オブ・
アメリカ社製の「カラー・ハーモニー・マニユア
ル」に記載されたものを用いた。観察は28℃で14
〜28日培養後に行なつた。
The present invention relates to a method for producing L-threo-β-hydroxyaspartic acid. L-threo-β-hydroxyaspartic acid itself has antibacterial activity. That is, Bacillus subtilis
subtilis), Xanthomonas oryzae, Mycobacterium
It is known to be effective against bacteria such as Mycobacterium phlei and Botrytis cinerea (Reference 1).
Ishiyama et al., Journal of Antibiotics, vol. 23,
821 pages, 1975). On the other hand, this substance can be regarded as an analog of L-aspartic acid, which is a type of amino acid that plays an important role in living organisms, and is known to be involved in biological enzyme systems and have important physiological activities. There is. For example, L
-Aspartate β-decaboxylase (L-
Aspartate β-decarboxylase) is known to be an inhibitor of (Reference 2. EWMiles and
A. Meister, Biochemistry vol. 6, p. 1734, 1967
Year). In addition, N-
It has been reported that L-threo-β-hydroxyaspartate suppresses the absorption of methyl-D-aspartate in the cerebral cortex (Reference 3.JH
Skerritt and G. AR Johnston, Journal of
Neurochemistry, vol. 36, p. 881, 1981). As mentioned above, L-threo-β-hydroxyaspartic acid is not only useful in itself as an antibacterial agent and a physiologically active substance, but also in the synthesis of pharmaceuticals and other industrially useful compounds if it can be supplied at low cost as a type of amino acid. It is likely to be used as a raw material or raw material. Although it is possible to produce this substance by extracting and purifying it from animals and plants, it is industrially disadvantageous because of the limitations on raw materials and the low content. Although synthetic methods are possible and various methods are known, β-hydroxyaspartic acid has four stereoisomers: the threo type, the erythro type, and their D and L forms. It is not necessarily an industrially advantageous method because it is necessary to generate L-threo isomers and isolate only the L-threo isomers. In contrast to these methods, the fermentation method using microorganisms can be said to be an industrially extremely advantageous production method because it can efficiently produce only compounds limited to specific stereoisomers. Arthrinium phaeospermum, a type of fungus, is a microorganism that ferments and produces L-threo-β-hydroxyaspartic acid.
phaeospermum) and one strain of Streptomyces, an actinomycete, is known (Reference 1). The present inventors discovered that a strain of the actinomycete Dactylosporangium was found to be L-threo-
The present invention was completed based on the discovery that it has the ability to ferment and produce β-hydroxyaspartic acid, and that it can be efficiently produced and accumulated in the culture solution at a high concentration. The method will be explained below. An example of a microbial strain used in the present invention is strain SF-2253, which belongs to the genus Dactylosporangium and was isolated by the present inventors from soil in Kyoto City. science fiction
The mycological properties of strain -2253 are as described below. Observations were mainly made using the methods of EBShirling and D. Gottlieb (International Journal of Systematic
Bacteriology, Vol. 16, pp. 313-340, 1966). Morphology The basal hyphae are well branched and elongate in a wavy manner, with a diameter of
It is 0.5-0.6 micron. No fragmentation of the basal hyphae was observed in either the agar medium or the liquid medium. Aerial hyphae are rarely seen and appear to virtually never form. SF-2253 strain forms a single sporangium or a tuft-like sporangium on the surface of the agar medium. Sporangia are found in relatively large numbers on starch agar media. The sporangia are finger-shaped and approximately 0.7 in size.
~1.0 x 2.0~4.0 microns. Each sporangium usually has 3 to 4 spores in a row within it. Spores are mostly cylindrical or oval in shape, with smooth surfaces and approximately 0.6-0.9 x 0.9-1.8 microns in size. The spores were suspended in, for example, a soil extract, left to stand for 15 to 30 minutes, and then examined under a microscope and found to be motile. Growth status on various media The growth status of SF-2253 strain on various media is as shown in the following table. In the description of colors, the standards shown in [ ] are those of Container Corporation of
The one described in the "Color Harmony Manual" manufactured by America Inc. was used. Observations were made at 28℃ 14
This was done after ~28 days of culture.
【表】【table】
【表】
生理的性質
(1) 生育温度範囲:スターチ寒天において15〜40
℃の温度範囲で生育し、25〜37℃で良好に生育
する。
(2) ゼラチンの液化:陰性
(3) スターチの加水分解:陽性
(4) 硝酸塩の還元:陰性
(5) 脱脂乳の凝固:陰性
脱脂乳のペプトン化:陰性
(6) メラニン様色素の生成:陰性
(7) 耐塩性:1.5%では生育するが、3.0%以上で
は生育しない。
炭素源の利用性[Table] Physiological properties (1) Growth temperature range: 15 to 40 on starch agar
It grows in a temperature range of 25°C to 37°C. (2) Liquefaction of gelatin: Negative (3) Hydrolysis of starch: Positive (4) Reduction of nitrate: Negative (5) Coagulation of skim milk: Negative Peptonization of skim milk: Negative (6) Production of melanin-like pigments: Negative (7) Salt tolerance: Grows at 1.5%, but does not grow at 3.0% or higher. Carbon source availability
【表】
細胞壁組成
ベツカー等の方法〔Appl.Microbiol.13:236
(1965)参照〕により分析した結果、細胞壁組成
成分中のジアミノピメリン酸は主にヒドロキシ型
であつた。
以上の性状よりSF−2253株は放線菌の中でダ
クチロスポランギウム属に属する菌株であるが、
ダクチロスポランギウム属に属する菌株がL−ス
レオ−β−ヒドロキシアスパラギン酸を生産する
ことは知られていない。
従つて、本発明者等はSF−2253株をダクチロ
スポランギウム・エシピー・SF−2253と命名し
た。なお、ダクチロスポランギウム・エスピー・
SF−2253株は工業技術院微生物工業研究所に受
託番号、微工研菌寄第6858号として寄託されてい
る。
上記にその性状が明らかとなつたSF−2253株
を用いL−スレオ−β−ヒドロキシアスパラギン
酸を生産するに当り、以下にその概要を説明す
る。
ダクチロスポランギウム・エスピーSF−2253
株は、他の放線菌の場合にみられるように、その
性状が変化しやすく、例えば紫外線、エツクス
線、放射線、薬品等を用いる人工的変異手段で変
異しうるものであり、このような変異株であつて
もL−スレオ−β−ヒドロキシアスパラギン酸の
生産能を有するダクチロスポランギウム属の菌は
すべて本発明の方法に使用することができる。
本発明の方法では、SF−2253株を通常微生物
が利用しうる栄養物を含有する培地で培養する。
例えば炭素源としてグルコース、シユクロース、
デキストリン、澱粉、水あめ、糖みつ、大豆油等
を使用しうる。また、窒素源として大豆粉、小麦
胚芽、ペプトン、肉エキス、酵母エキス、コーン
ステイープリカー、硝酸ナトリウム、硫酸アンモ
ニウム等を使用しうる。その他必要に応じて炭酸
カルシウム、塩化カリウム、燐酸塩等の無機塩類
を添加するほか菌の発育を助け、L−スレオ−β
−ヒドロキシアスパラギン酸の生産を促進するよ
うな有機物及び無機物を適当に添加することがで
きる。
培養法としては、一般の微生物の培養方法と同
じく液体培養法、特に深部撹拌培養法が最も適し
ている。培養は好気的条件下で行なわれ、培養に
適した温度は25℃〜40℃であるが、通常30℃付近
で培養し、PHは中性〜弱アルカリ性が望ましい。
液体培養法で通常3〜10日間培養を行なうと、L
−スレオ−β−ヒドロキシアスパラギン酸が培養
液中に生成蓄積される。
L−スレオ−β−ヒドロキシアスパラギン酸の
検定方法は本物質が抗菌活性を有するので一般に
抗生物質の検定に用いられるバイオアツセイ法が
適用出来る。即ち検定菌としてバチルス・ズブチ
リスPCI−219(Bacillus subtilis)を用いペプト
ン0.5%と寒天1.5%(殺菌前PH7)から成る検定
シヤーレを作成し、被検液を浸積したペーパーデ
イスク(直径8mm)を検定シヤーレ上に置き37
℃、17時間培養すると、被検体の濃度に応じた発
育阻止円が見られる。阻止円径とL−スレオ−β
−ヒドロキシアスパラギン酸の濃度の対数が一定
の範囲で直線的相関関係にあり、この場合100μ
g/ml〜2000μg/mlの濃度範囲で定量出来る。
培養液内に生産、蓄積されたSF−2253物質を
単離精製するには、水溶性酸性物質の精製に通常
用いられる手段を適宜利用することが出来る。即
ち、ダイヤイオンHP−20(三菱化成製)、アンバ
ーライトXAD−2(ロームアンドハース社製)、
炭末等の吸着剤;セフアデツクスG−10(フアル
マシア製)、トヨパールHW−40(東洋ソーダ社
製)等のゲル濾過剤;ダウエツクス1×2(ダウ
ケミカル社製)、ダイヤイオンPA−306(三菱化成
製)、DEAE−セフアデツクス(フアルマシア製)
等の陰イオン交換樹脂等によるクロマトグラフイ
ーが使用されるが、以下による精製方法が効率的
である。
SF−2253株の培養液をハイフロスーパーセル
等の濾過助剤を用いて菌体その他の固型物を除去
し、次いで濾過中の有効成分をダウエツクス1×
2(Cl-)に吸着させ、0.5M NaCl水で溶出させ
る。この溶離液をセルロースカラム、セフアデツ
クスG−10等のカラムクロマトグラフイー;メト
ノール、エタノール等の有機溶剤による沈澱等を
適宜組み合わせることにより高純度のSF−2253
物質を得ることができる。
以下に本発明によつて得られたL−スレオ−β
−ヒドロキシアスパラギン酸の理化学的性状を示
す。
(1) 外観:白色針状結晶
(2) 融点:200℃付近より徐々に褐変する。
(3) 元素分析値:C 33.36%、H 4.69%、N
9.13%、O 52.82%
(4) 分子量:149(FD マススペクトルによる)
(5) 紫外部吸収スペクトル:220nm〜370nmに
特徴的な吸収極大がない。
(6) 赤外部吸収スペクトル(臭化カリウム法):
第1図に示す。
1725、1660、1500、1160、1100、1040及び
970cm-1に特徴的吸収が見られる。
(7) 溶解性
アルカリ性または酸性水及び温水に良く溶
け、水に可溶、メタノール、クロロホルム、酢
酸エチル、ヘキサン、ベンゼン、エーテル等の
有機溶剤に実質的に不溶である。
(8) 安定性
酸性、中性、アルカリ性いずれにおいても安
定である。
(9) シリカゲル薄層クロマトグラフイーのR値
n−プロパノール−ピリジン−酢酸−水(15:
10:3:12) 0.5
エタノール−水(7:3) 0.3
(10) ペーパークロマトグラフイーのR値(上昇
法)n−プロパノール−ピリジン−酢酸−水
(15:10:3:12) 0.22
n−ブタノール−酢酸−水(2:1:1) 0.14
(11) 呈色反応
陽性:ニンヒドリン、レミユー、ヨウ素反応
陰性:硫酸、坂口反応
(12) 高圧濾紙電気泳動(3500V、20分)
ギ酸−酢酸−水(PH1.9)(20:80:900、V/
V) Rm(Lys)0.19
ピリジン−酢酸−水(PH6.4)(200:8:2890、
V/V) Rm(Glu)1.14
(13) 比旋光度
〔α〕365+38.0°(C 0.5、1N HCl)
(14) 重水中で測定した水素核磁気共鳴スペクト
ル(100MPH、TMS 外部標準)では4.07
(1Hd、J=2Hz)及び4.55ppm(1Hd、J=2
Hz)にシグナルが見られる。
(15) 重水中で測定した炭素核磁気共鳴スペクト
ル(25MHz、dioxane 外部標準)では57.8(d)、
71.5(d)、173.0(s)及び177.2(s)にシグナルが見ら
れる。
以下に本発明の方法につき実施例にもとずき説
明する。
実施例 1
種培地としてスターチ2.0%、グルコース1.0
%、小麦胚芽0.6%、ペプトン0.5%、イーストエ
クストラクト0.3%、大豆粉0.2%および炭酸カル
シウム0.1%を含む培地を用いた。また、生産培
地として水飴2.0%、大豆油0.15%、大豆粉1.0%、
「サングレイン」(サントリー社製)0.25%、綿実
粕0.5%、炭酸カルシウム0.1%、硫酸第一鉄
0.0005%、塩化ニツケル0.00005%および塩化コ
バルト0.00005%を含む培地を用いた。殺菌前の
培地のPHは全て7に調節し実施した。
イーストエキストラクト・マルトエキストラク
ト寒天スラントに十分生育したダクチロスポラン
ギウム・エスピーSF−2253株(微工研菌寄第
6858号)を上記殺菌種培地20mlを含む100ml容三
角フラスコ2本に6〜7白金耳接種し、28℃で6
日間培養し、第1種培養液とした。次いで、殺菌
種培地100mlを含む500ml容の三角フラスコ2本に
前記の第1種培養液4mlずつを接種し、28℃で2
日間振盪培養し、これを第2種培養液とした。次
いで、殺菌種培地1を含む5容の三角フラス
コ2本に前記の第2種培養液50mlずつを接種し、
28℃で2日間振盪培養し、これを第3種培養液と
した。次いで、この第3種培養液を35の殺菌生
産培地を含む50容のジヤーフアーメンター2基
に接種し、28℃で5日間通気、撹拌培養した(回
転数270rpm、通気量35/min)。培養終了後、
ケイソウ土を助剤に用いて濾過し、培養濾液40
を得た。バイオアツセイによるL−スレオ−β−
ヒドロキシアスパラギン酸の生産量は1100μg/
mlであつた。
実施例 2
実施例1で得た培養濾液40をPH2に調整後、
活性炭4を充填した塔に通した。その通過液を
ダウエツクス1×2(Cl-)(ダウケミカル社製)
4を充填した塔に通し有効成分を吸着させた。
吸着後、この塔を12の水で洗浄し、0.2M塩化
ナトリウム溶液で溶離すると、5分画でフラク
シヨンNo.1及び2に有効成分が溶出された。この
フラクシヨンを約30mlになるまで減圧濃縮した。
このとき析出した塩化ナトリウムの結晶は濾過し
て除き、瀘液をセフアデツクスG−10(フアルマ
シア社製)1.2を充填した塔に付し水で展開す
ると、フラクシヨンNo.27〜49(18ml分画)にかけ
て有効物質が溶出された。
活性フラクシヨン360mlを集め、減圧濃縮して
凍結乾燥したところ、淡黄色のL−スレオ−β−
ヒドロキシアスパラギン酸ナトリウムの粗粉末が
31.5g得られた。
次いで、この粗粉末を50%含水エタノールで溶
解後、あらかじめ90%エタノール水で洗浄したカ
ラムクロマト用セルロース(ワツトマン社製)1
を充填した塔につけ、90%エタノール水1で
洗浄後、70%エタノール水3.5及び50%エタノ
ール水2で各々展開すると、フラクシヨンNo.
137〜278(18ml分画)にかけて有効物質が溶出さ
れた。この活性フラクシヨン2.5を減圧濃縮し
凍結乾燥することにより淡黄色のL−スレオ−β
−ヒドロキシアスパラギン酸ナトリウムの精製粉
末が14.8g得られた。
次に、このうちの3.5gを水5mlに溶解させ、
PH2に調整後、エタノール50mlを加えると沈澱が
2.72g生成した。この沈澱を温水20mlに加え塩酸
でPH2に調節し溶解させた。この溶液が少し白く
濁るまでエタノールを加え、5℃で一晩静置する
とL−スレオ−β−ヒドロキシアスパラギン酸の
白色結晶が析出し、これを濾別し減圧下に乾燥し
て白色針状結晶2.41gを得た。[Table] Cell wall composition Method of Betzker et al. [Appl.Microbiol.13:236
(1965)] showed that diaminopimelic acid in the cell wall composition was mainly in the hydroxy type. Based on the above properties, strain SF-2253 is a strain that belongs to the genus Dactylosporangium among actinomycetes.
It is not known that strains belonging to the genus Dactylosporangium produce L-threo-β-hydroxyaspartic acid. Therefore, the present inventors named the SF-2253 strain Dactyrosporangium escipi SF-2253. In addition, Dactyrosporangium sp.
Strain SF-2253 has been deposited with the Institute of Microbiology, Agency of Industrial Science and Technology under accession number 6858. The outline of the production of L-threo-β-hydroxyaspartic acid using the SF-2253 strain whose properties have been clarified above will be explained below. Dactylosporangium sp. SF-2253
Strains, as seen in the case of other actinomycetes, are susceptible to changes in their properties and can be mutated by artificial mutagenic means using, for example, ultraviolet rays, X-rays, radiation, chemicals, etc.; All strains of Dactyrosporangium that have the ability to produce L-threo-β-hydroxyaspartic acid can be used in the method of the present invention. In the method of the present invention, strain SF-2253 is cultured in a medium containing nutrients that can be used by microorganisms.
For example, glucose, sucrose,
Dextrin, starch, starch syrup, molasses, soybean oil, etc. can be used. Further, soybean flour, wheat germ, peptone, meat extract, yeast extract, cornstarch liquor, sodium nitrate, ammonium sulfate, etc. can be used as the nitrogen source. In addition to adding inorganic salts such as calcium carbonate, potassium chloride, and phosphates as necessary, L-threo-β
- Organic and inorganic substances that promote the production of hydroxyaspartic acid can be appropriately added. The most suitable culture method is the liquid culture method, especially the deep agitation culture method, as is the case with general microbial culture methods. Cultivation is performed under aerobic conditions, and the temperature suitable for cultivation is 25°C to 40°C, but it is usually cultured at around 30°C, and the pH is preferably neutral to slightly alkaline.
When cultured for 3 to 10 days using the liquid culture method, L
-Threo-β-hydroxyaspartic acid is produced and accumulated in the culture solution. As a method for assaying L-threo-β-hydroxyaspartic acid, a bioassay method generally used for assaying antibiotics can be applied since this substance has antibacterial activity. That is, using Bacillus subtilis PCI-219 (Bacillus subtilis) as the test bacterium, a test dish consisting of 0.5% peptone and 1.5% agar (PH7 before sterilization) was prepared, and a paper disk (diameter 8 mm) soaked with the test solution was placed. Place it on the certification sheet 37
After culturing at ℃ for 17 hours, a growth inhibition circle corresponding to the concentration of the test substance can be seen. Inhibition circle diameter and L-threo-β
- The logarithm of the concentration of hydroxyaspartic acid has a linear correlation within a certain range, in this case 100μ
It can be quantified in the concentration range of g/ml to 2000 μg/ml. In order to isolate and purify the SF-2253 substance produced and accumulated in the culture solution, any means commonly used for purifying water-soluble acidic substances can be used as appropriate. Namely, Diaion HP-20 (manufactured by Mitsubishi Kasei), Amberlite XAD-2 (manufactured by Rohm and Haas),
Adsorbents such as charcoal powder; Gel filtration agents such as Cephadex G-10 (manufactured by Pharmacia) and Toyopearl HW-40 (manufactured by Toyo Soda Co.); (manufactured by Chemicals), DEAE-Sephadex (manufactured by Pharmacia)
Although chromatography using an anion exchange resin such as the following is used, the following purification method is efficient. The culture solution of SF-2253 strain is filtered using a filter aid such as Hyflo Super Cell to remove bacterial cells and other solid substances, and then the active ingredients during filtration are removed using Dowex 1x.
2 (Cl - ) and elute with 0.5M NaCl water. This eluent is subjected to column chromatography such as a cellulose column or Sephadex G-10; precipitation with an organic solvent such as methanol or ethanol, etc., to obtain high purity SF-2253.
substance can be obtained. Below, L-threo-β obtained by the present invention
- Shows the physical and chemical properties of hydroxyaspartic acid. (1) Appearance: White needle-like crystals (2) Melting point: Gradually turns brown from around 200℃. (3) Elemental analysis values: C 33.36%, H 4.69%, N
9.13%, O 52.82% (4) Molecular weight: 149 (according to FD mass spectrum) (5) Ultraviolet absorption spectrum: No characteristic absorption maximum between 220 nm and 370 nm. (6) Infrared absorption spectrum (potassium bromide method):
Shown in Figure 1. 1725, 1660, 1500, 1160, 1100, 1040 and
A characteristic absorption is seen at 970 cm -1 . (7) Solubility Well soluble in alkaline or acidic water and hot water, soluble in water, and virtually insoluble in organic solvents such as methanol, chloroform, ethyl acetate, hexane, benzene, and ether. (8) Stability Stable in acidic, neutral, and alkaline conditions. (9) R value of silica gel thin layer chromatography n-propanol-pyridine-acetic acid-water (15:
10:3:12) 0.5 Ethanol-Water (7:3) 0.3 (10) Paper chromatography R value (ascending method) n-Propanol-Pyridine-acetic acid-Water (15:10:3:12) 0.22 n -Butanol-acetic acid-water (2:1:1) 0.14 (11) Positive color reaction: Ninhydrin, Remieux, iodine reaction Negative: sulfuric acid, Sakaguchi reaction (12) High-pressure filter paper electrophoresis (3500V, 20 minutes) Formic acid-acetic acid -Water (PH1.9) (20:80:900, V/
V) Rm (Lys) 0.19 Pyridine-acetic acid-water (PH6.4) (200:8:2890,
V/V) Rm (Glu) 1.14 (13) Specific rotation [α] 365 +38.0° (C 0.5, 1N HCl) (14) Hydrogen nuclear magnetic resonance spectrum measured in heavy water (100MPH, TMS external standard) So 4.07
(1Hd, J=2Hz) and 4.55ppm (1Hd, J=2Hz)
Hz). (15) Carbon nuclear magnetic resonance spectrum (25MHz, dioxane external standard) measured in heavy water shows 57.8(d);
Signals can be seen at 71.5(d), 173.0(s) and 177.2(s). The method of the present invention will be explained below based on examples. Example 1 Starch 2.0%, glucose 1.0 as seed medium
%, wheat germ 0.6%, peptone 0.5%, yeast extract 0.3%, soybean flour 0.2% and calcium carbonate 0.1%. In addition, as production medium, starch syrup 2.0%, soybean oil 0.15%, soybean flour 1.0%,
"Sungrain" (manufactured by Suntory) 0.25%, cottonseed meal 0.5%, calcium carbonate 0.1%, ferrous sulfate
A medium containing nickel chloride 0.00005% and cobalt chloride 0.00005% was used. The pH of the culture medium before sterilization was adjusted to 7 in all cases. Dactyrosporangium sp. SF-2253 strain (Fiber Science and Technology Research Institute), which grew well on yeast extract/malt extract agar slant.
6858) into two 100 ml Erlenmeyer flasks containing 20 ml of the above sterilized seed medium, and inoculated with 6 to 7 platinum loops at 28℃.
The cells were cultured for days and used as a type 1 culture solution. Next, 4 ml of the above-mentioned type 1 culture solution was inoculated into two 500 ml Erlenmeyer flasks containing 100 ml of sterilized seed medium, and incubated at 28°C for 2 hours.
The culture was cultured with shaking for several days, and this was used as a second type culture solution. Next, 50 ml each of the second type culture solution was inoculated into two 5-volume Erlenmeyer flasks containing sterilized seed medium 1,
The culture was cultured with shaking at 28° C. for 2 days, and this was used as a third type culture solution. Next, this third type culture solution was inoculated into two 50-volume jar fermenters containing 35 sterilized production medium, and cultured with aeration and stirring at 28°C for 5 days (rotation speed 270 rpm, aeration rate 35/min). . After culturing,
Filter using diatomaceous earth as an auxiliary agent, and culture filtrate 40
I got it. L-threo-β- by bioassay
The production amount of hydroxyaspartic acid is 1100μg/
It was hot in ml. Example 2 After adjusting the culture filtrate 40 obtained in Example 1 to pH 2,
It was passed through a column filled with activated carbon 4. The passing liquid was treated with Dowex 1×2 (Cl - ) (manufactured by Dow Chemical Company).
The active ingredients were adsorbed through a column packed with 4.
After adsorption, the column was washed with 12 portions of water and eluted with 0.2M sodium chloride solution, and the active ingredient was eluted in fractions No. 1 and 2 in 5 fractions. This fraction was concentrated under reduced pressure to about 30 ml.
The sodium chloride crystals precipitated at this time were removed by filtration, and the filtrate was passed through a tower filled with 1.2 Cefdex G-10 (manufactured by Pharmacia) and developed with water, resulting in fractions No. 27 to 49 (18 ml fractions). The active substance was eluted over time. When 360 ml of the active fraction was collected, concentrated under reduced pressure and lyophilized, a pale yellow L-threo-β-
Coarse powder of sodium hydroxyaspartate
31.5g was obtained. Next, after dissolving this coarse powder in 50% aqueous ethanol, cellulose for column chromatography (manufactured by Watmann) 1, which had been previously washed with 90% ethanol water, was dissolved.
After washing with 1 part of 90% ethanol water and developing with 3.5 parts of 70% ethanol water and 2 parts of 50% ethanol water, fraction No.
The active substance was eluted between 137 and 278 (18 ml fraction). This active fraction 2.5 was concentrated under reduced pressure and freeze-dried to produce a pale yellow L-threo-β.
-14.8g of purified powder of sodium hydroxyaspartate was obtained. Next, dissolve 3.5g of this in 5ml of water,
After adjusting the pH to 2, add 50ml of ethanol to form a precipitate.
2.72g was produced. This precipitate was added to 20 ml of warm water, adjusted to pH 2 with hydrochloric acid, and dissolved. Add ethanol until the solution becomes slightly cloudy and leave it at 5°C overnight to precipitate white crystals of L-threo-β-hydroxyaspartic acid, which are filtered and dried under reduced pressure to produce white needle-like crystals. 2.41g was obtained.
第1図はL−スレオ−β−ヒドロキシアスパラ
ギン酸の臭化カリウム錠剤での赤外部吸収スペク
トルである。
FIG. 1 is an infrared absorption spectrum of L-threo-β-hydroxyaspartic acid in potassium bromide tablets.
Claims (1)
オ−β−ヒドロキシアスパラギン酸生産能を有す
る菌株を栄養培地中に培養し、培養物よりL−ス
レオ−β−ヒドロキシアスパラギン酸を採取する
ことを特徴とするL−スレオ−β−ヒドロキシア
スパラギン酸の製造法。 2 ダクチロスポランギウム属に属し、L−スレ
オ−β−ヒドロキシアスパラギン酸生産能を有す
る菌株がダクチロスポランギウム・エスピ−SF
−2253株(FERM P−6858)である特許請求の
範囲第1項記載の製造法。[Scope of Claims] 1. A strain belonging to the genus Dactylosporangium and having the ability to produce L-threo-β-hydroxyaspartic acid is cultured in a nutrient medium, and L-threo-β-hydroxyaspartic acid is extracted from the culture. 1. A method for producing L-threo-β-hydroxyaspartic acid, which comprises collecting L-threo-β-hydroxyaspartic acid. 2. A strain that belongs to the genus Dactylosporangium and has the ability to produce L-threo-β-hydroxyaspartic acid is Dactylosporangium sp.
-2253 strain (FERM P-6858).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4701883A JPS59173089A (en) | 1983-03-23 | 1983-03-23 | Preparation of l-threo-beta-hydroxyaspartic acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4701883A JPS59173089A (en) | 1983-03-23 | 1983-03-23 | Preparation of l-threo-beta-hydroxyaspartic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59173089A JPS59173089A (en) | 1984-09-29 |
JPH0361437B2 true JPH0361437B2 (en) | 1991-09-19 |
Family
ID=12763432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4701883A Granted JPS59173089A (en) | 1983-03-23 | 1983-03-23 | Preparation of l-threo-beta-hydroxyaspartic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59173089A (en) |
-
1983
- 1983-03-23 JP JP4701883A patent/JPS59173089A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59173089A (en) | 1984-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4312948A (en) | Enzymic microbiological process for producing optically active aminoacids starting from hydantoins and/or racemic carbamoyl derivatives | |
JPH0361437B2 (en) | ||
JP2620795B2 (en) | Method for producing colominic acid | |
US3975235A (en) | Process for the production of cephamycin type antibiotic substances | |
JP2936663B2 (en) | Method for producing FR901228 substance | |
JP2594167B2 (en) | Novel antibiotic SF2698 substance and its production method | |
DE2241091C3 (en) | ||
US4086138A (en) | Process for producing glucose isomerase | |
JP3858061B2 (en) | Novel chitinase inhibitor and process for producing the same | |
JPH072116B2 (en) | Method for producing difructose and dianhydride III | |
DE2241091B2 (en) | PROCESS FOR THE PREPARATION OF 7- (D-ALPHA-AMINOPHENYLACETOAMIDO) -DESACE- TOXY-CEPHALOSPORANIC ACID | |
JPH01228465A (en) | Novel beta-agarase and production thereof | |
JPH08275776A (en) | New chitinase and its production | |
JPS62210996A (en) | Production of antibiotic substance emimycin | |
JPH01238579A (en) | Substance y-05460m-a and production thereof | |
JPH01296992A (en) | Substance fr-900493, production thereof and drug composition containing the same substance | |
JPS6250474B2 (en) | ||
JPS60180582A (en) | Novel microorganism | |
JPS61199797A (en) | New adechlorine and its preparation | |
JPH0632628B2 (en) | Method for producing difructo-sujian hydride (I) | |
JPS61289898A (en) | Production of factor for suppressing sporulation of phytopathogenic fungus | |
JPH0737478B2 (en) | Novel bioactive substance KSA-9342 or salt thereof, and method for producing the same | |
JPH02163082A (en) | Production of chitosanase | |
JPS58183097A (en) | Novel antibiotic ef-70147-y and its preparation | |
JPS5945894A (en) | Preparation of coenzyme q10 |